Ibuprofeno Ambah (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are key in the conversion of arachidonic acid to prostaglandins. By lowering prostaglandin production, it diminishes peripheral sensitization, reduces the hypothalamic fever set‑point, and limits inflammatory mediators, producing analgesic, antipyretic, and anti‑inflammatory effects.

The specific dose and infusion rate of Ibuprofeno Ambah are determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and renal function. Healthcare providers follow local guidelines and product labeling to select an appropriate dosage regimen for each individual case.

Safety data for intravenous ibuprofen in pregnancy and lactation are limited, and the product is generally classified as contraindicated or to be used only if the potential benefit outweighs the risk. Clinicians should evaluate maternal and fetal considerations and consider alternative therapies when safer options are available.

To request Ibuprofeno Ambah, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including any cold‑chain requirements—and necessary import documentation.

Compared with other injectable NSAIDs such as ketorolac or diclofenac, ibuprofen offers a broader therapeutic window for pain, fever and inflammation with a well‑characterized safety profile. It provides comparable analgesia but may have a lower risk of renal toxicity at standard doses, though individual patient factors and drug‑specific contraindications must guide selection.

Ibuprofeno Ambah must be stored refrigerated at 2 °C to 8 °C. The vials should be kept in their original packaging, protected from light, and must not be frozen or shaken. If the product reaches room temperature, it should be used promptly and not re‑refrigerated.

The medication is supplied as a sterile solution for intravenous injection. It is administered by a qualified healthcare professional, typically as a slow infusion over 15–30 minutes, depending on the prescribed dose and patient tolerance. Proper aseptic technique and infusion set compatibility are essential to ensure safe delivery.

The most serious adverse reactions include gastrointestinal bleeding, acute renal impairment, severe allergic reactions such as anaphylaxis, and hepatotoxicity. Patients with a history of ulcers, kidney disease, or hypersensitivity to NSAIDs should be closely monitored, and any signs of bleeding, sudden loss of kidney function, or allergic symptoms require immediate medical attention.

Ibuprofeno Ambah is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulceration, severe renal or hepatic impairment, and in those receiving anticoagulant therapy where bleeding risk is unacceptable. It should also be avoided in individuals with a history of asthma exacerbated by NSAIDs unless the prescriber determines that benefits outweigh the risks.